Acta Med. 2008, 51: 185-190

Monitoring of Serum Levels of Angiogenin, ENA-78 and GRO Chemokines in Patients with Renal Cell Carcinoma (RCC) in the Course of the Treatment

Dagmar Hlávkováa, Otakar Kopeckýb,c, Šárka Lukešováb,c, Vladimíra Vroblováa, Ctirad Andrýsa, Petr Morávekd, Miroslav Podholae, Doris Vokurkováa, Hynek Šafránekd

aCharles University in Prague, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Department of Clinical Immunology and Allergology, Hradec Králové, Czech Republic
bCharles University in Prague, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Oncological Department of District Hospital, Náchod, Czech Republic
cCharles University in Prague, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, 2nd Department of Internal Medicine, Hradec Králové, Czech Republic
dCharles University in Prague, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Department of Urology, Hradec Králové, Czech Republic
eCharles University in Prague, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Fingerland’s Department of Pathology, Hradec Králové, Czech Republic

Received December 1, 2007
Accepted June 1, 2008


1. Avniel S, Arik Z, Maly A, et al. Involvement of the CXC12/CXC4 pathway in the recovery of skin following burns. J Invest Dermatol 2006; 16:468–476. <>
2. Brigati C, Noonan DM, Albini A, Benelli R. Tumors and inflammatory infiltrates: Friends or foes? Clin Exp Metastasis 2002; 19:247–258. <>
3. Coussens LM, Werb Z. Inflammation and Cancer. Nature 2002; 420:860–867. <> <PubMed>
4. Fett JB, Strydom DJ, Lobb RR, et al. Isolation and characterisation of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 1985; 24:5480–5486. <>
5. Garkavtsev I, Kozin SV, Chernova O, et al. The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis. Nature 2004; 428: 328–332. <>
6. Hartmann A, Kunz M, Kostlin S, et al. Hypoxya induced up-regulation of angiogenin in human malignant melanoma. Cancer Res 1999; 59:1578–1983.
7. Huang RP, Huang R, Fan Y, Lin Y. Simultaneous detection of multiple cytokines from conditioned media and patient’s sera by an antibody-based protein array system. Anal Biochem 2001; 294:55–62. <>
8. Luan J, Shattuck-Brandt R, Haghnegahdar H, et al. Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression. J Leukoc Biol 1997; 62:588–97. <>
9. Mestas J, Burdick MD, Reckamp K, Pantuck A, Figlin RA, Strieter RM. The role of CXC2/CXCR2 ligand biological axis in renal cell carcinoma. J Immunol 2005; 175:5351–5357. <>
10. Mu W, Ouyang X, Agarwal A, et al. IL-10 Suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease. J Am Soc Nephrol 2005; 16: 3651–3660. <>
11. Murdoch C, Finn A. Chemokine receptors and their role in inflammation and infectious diseases. Blood 2000; 95:3032–3043.
12. Riese J, Schoolmann S, Beyer A, Denzel C, Hohenberger W, Haupt W. Production of IL-6 and MCP-1 by the human peritoneum in vivo during major abdominal surgery. Shock 2000; 14(2):91–4. <>
13. Schoppmann SF, Birner P, Stöckl J, et al. Tumor-Associated Macrophages Express Lymphatic Endothelial Growth Factors and Are Related to Peritumoral Lymphangiogenesis. Am J Pathol 2002; 161:947–956. <> <PubMed>
14. Schröder A, von der Ohe M, Kolling U, et al. Polymorphonuclear leucocytes selectively produce anti-inflammatory interleukin-1 receptor antagonist and chemokines, but fail to produce pro-inflammatory mediators. Immunol 2006; 119: 317–327. <> <PubMed>
15. Scimone ML, Lutzky VP, Zittermann SI, et al. Migration of polymorphonuclear leucocytes is influenced by dendritic cells. Immunol 2005; 114:375–385. <> <PubMed>
16. Sido B, Teklote JR, Hartel M, Friess H, Buchler MW. Inflammatory response after abdominal surgery. Best Pract Res Clin Anaesthesiol 2004; 18:439–459. <>
17. Smith DF, Galkina E, Ley K, Huo Y. GRO family chemokines are specialized for monocyte arrest from flow. AJP-Heart Circ Physiol 2005; 76:1976–1984. <>
18. Strydom DJ. The angiogenin. Cell Mol Life Sci 1998; 54:811–824. <>
19. Tello-Montoliu A, Patel JV, Lip GY. Angiogenin: a review of the pathophysiology and potential clinical applications. J Thromb Haemost 2006; 4:1864–1874. <>
20. Tsung K, Dolan JP, Tsung YL, Norton JA. Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection. Cancer Res 2002; 62: 5069–75.
21. Wang CC, Huang RP, Sommer M, et al. Array-based multiplexed screening and quantitation of human cytokines and chemokines. J Proteome Res 2002; 4: 337–43. <>
22. Wechsel HW, Bichler KH, Feil G, Loeser W, Lahme S, Petri E. Renal cell carcinoma: relevance of angiogenetic factors. Anticancer Res 1999; 19:1537–1540.
23. Wetzler Ch, Kämpfer H, Stallmeyer B, Pfeilschifter J, Frank S. Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: Prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol 2000; 115:245–253. <>
24. Wu FP, Sietses C, von Blomberg BM, Meijer S, Bonjer HJ, Cuesta MA. Systemic and peritoneal angiogenic response after laparoscopic or conventional colon resection in cancer patients: a prospective, randomized trial. Dis Colon Rectum 2004; 47(10):1670–4. <>
25. Yatsunami J, Tsuruta N, Ogata K, et al. Interleukin-8 participates in angiogenesis in non-small cell, but not small cell carcinoma of the lung. Cancer Lett 1997; 120:101–108. <>
26. Zijlstra A, Seandel M, Kupriyanova TA, et al. Proangiogenic role of neutrophillike inflammatory heterophils during neovascularization induced by growth factors and human tumor cells. Blood 2006; 107:317–327. <> <PubMed>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal